References
- European Medicines Agency. Points to consider on GCP inspection findings and the benefit-risk balance. EMA; 2012. Available at: https://www.ema.europa.eu/documents/other/points-consider-good-clinical-practice-inspection-findings-benefit-risk-balance_en.pdf
- European Medicines Agency. Reflection paper on ethical and GCP aspects of clinical trials of medicinal products for human use conducted outside of the EU/EEA and submitted in marketing authorization applications to the EU Regulatory Authorities. EMA; 2012. Available at: https://www.ema.europa.eu/documents/regulatory-procedural-guideline/reflection-paper-ethical-good-clinical-practice-aspects-clinical-trials-medicinal-products-human-use/european-economic-area-submitted-marketing-autho_en.pdf
- European Medicines Agency. Procedure for coordinating GCP inspections requested by the CHMP. EMA; 2014. Available at: https://www.ema.europa.eu/documents/regulatory-procedural-guideline/ins-gcp-1-procedure-coordinating-good-clinical-practice-inspections-requested-chmp_en.pdf
- European Medicines Agency. Procedure for reporting of GCP inspections requested by the Committee for Medicinal Products for Human Use (CHMP). EMA; 2013. Available at: https://www.ema.europa.eu/documents/regulatory-procedural-guideline/ins-gcp-4-procedure-reporting-good-clinical-practice-inspections-requested-chmp_en.pdf
- European Medicines Agency. Classification and analysis of the GCP inspection findings of GCP inspections conducted at the request of the CHMP. EMA; 2014. Available at: https://www.ema.europa.eu/documents/other/classification-analysis-good-clinical-practice-gcp-inspection-findings-gcp-inspections-conducted_en.pdf
- Bernabe RDLC ,Van Thiel GJMW, Van Delden JJM. What do international ethics guidelines say in terms of the scope of medical research ethics? BMC Med Ethics 2016;17:1–18
- Charmaz K. Constructing grounded theory: a practical guide through qualitative analysis. London, Thousand Oaks, and New Delhi: Sage; 2006